MMG
ARKG icon

Monetary Management Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Monetary Management Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-650
Closed -$58K – 312
2021
Q1 		$58K Hold
650
– – 0.02% 233
2020
Q4 		$61K Hold
650
– – 0.02% 221
2020
Q3 		$41K Hold
650
– – 0.01% 224
2020
Q2 		$34K Buy
650
+200
+44% +$8.58K 0.01% 225
2020
Q1 		$14K Hold
450
– – 0.01% 246
2019
Q4 		$15K Hold
450
– – 0.01% 280
2019
Q3 		$13K Hold
450
– – ﹤0.01% 284
2019
Q2 		$16K Buy
+450
New +$14.4K 0.01% 277

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Monetary Management Group's ARKG Position: Q2 2021 in Review

Monetary Management Group sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 650 shares — an estimated $58K sold.

Monetary Management Group first reported a position in ARKG in Q2 2019 and held it in 8 quarters. The position peaked at $61K in Q4 2020. 512 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

  • Monetary Management Group reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
  • Monetary Management Group sold 650 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $58K.
  • Monetary Management Group first reported a position in ARK Genomic Revolution ETF in Q2 2019 and held it in 8 quarters.
  • Monetary Management Group's ARK Genomic Revolution ETF position peaked at $61K in Q4 2020.
  • 512 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on Monetary Management Group's 13F filing for Q2 2021, filed 12 Aug 2021.